1. Sliwa K, Hilfiker-Kleiner D, Petrie MC, Mebazaa A, Pieske B, Buchmann E et al. Current state of knowledge on aetiology, diagnosis, management, and therapy of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Working Group on peripartum cardiomyopathy. European Journal of Heart Failure. 2010;12(8):767–78. DOI: 10.1093/eurjhf/hfq120
2. Elkayam U, Akhter MW, Singh H, Khan S, Bitar F, Hameed A et al. Pregnancy-Associated Cardiomyopathy: Clinical Characteristics and a Comparison Between Early and Late Presentation. Circulation. 2005;111(16):2050–5. DOI: 10.1161/01.CIR.0000162478.36652.7E
3. Pyatt JR, Dubey G. Peripartum cardiomyopathy: current understanding, comprehensive management review and new developments. Postgraduate Medical Journal. 2011;87(1023):34–9. DOI: 10.1136/pgmj.2009.096594
4. Patten IS, Rana S, Shahul S, Rowe GC, Jang C, Liu L et al. Cardiac angiogenic imbalance leads to peripartum cardiomyopathy. Nature. 2012;485(7398):333–8. DOI: 10.1038/nature11040
5. Bauersachs J, Konig T, Meer P, Petrie MC, Hilfiker-Kleiner D, Mbakwem A et al. Pathophysiology, diagnosis and management of peripartum cardiomyopathy: a position statement from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure. 2019;21(7):827–43. DOI: 10.1002/ejhf.1493
6. Behrens I, Basit S, Lykke JA, Ranthe MF, Wohlfahrt J, Bundgaard H et al. Hypertensive disorders of pregnancy and peripartum cardiomyopathy: A nationwide cohort study. PLOS ONE. 2019;14(2):e0211857. DOI: 10.1371/journal.pone.0211857
7. Ватутин Н.Т., Тарадин Г.Г., Попелнухина Л.Г., Гриценко Ю.П., Сидоренко И.А. Лечение перипартальной кардиомиопатии (обзор литературы). Архивъ внутренней медицины. 2017;7(5):340-9. DOI: 10.20514/2226-6704-2017-7-5-340-349
8. Hilfiker-Kleiner D, Kaminski K, Podewski E, Bonda T, Schaefer A, Sliwa K et al. A Cathepsin D-Cleaved 16 kDa Form of Prolactin Mediates Postpartum Cardiomyopathy. Cell. 2007;128(3):589–600. DOI: 10.1016/j.cell.2006.12.036
9. Курбанов Р.Д., Мирзарахимова С.Т., Абдуллаев Т.А., Цой И.А. Влияние бромокриптина на клинические и лабораторные показатели у больных с перипартальной кардиомиопатией. Кардиология. 2020;60(6):58–62. DOI: 10.18087/cardio.2020.6.n984
10. Arany Z, Elkayam U. Peripartum Cardiomyopathy. Circulation. 2016;133(14):1397–409. DOI: 10.1161/CIRCULATIONAHA.115.020491
11. Bauersachs J, Arrigo M, Hilfiker-Kleiner D, Veltmann C, Coats AJS, Crespo-Leiro MG et al. Current management of patients with severe acute peripartum cardiomyopathy: practical guidance from the Heart Failure Association of the European Society of Cardiology Study Group on peripartum cardiomyopathy. European Journal of Heart Failure. 2016;18(9):1096–105. DOI: 10.1002/ejhf.586
12. Fett JD, Sannon H, Thelisma E, Sprunger T, Suresh V. Recovery from severe heart failure following peripartum cardiomyopathy. International Journal of Gynecology & Obstetrics. 2009;104(2):125–7. DOI: 10.1016/j.ijgo.2008.09.017
13. Hilfiker-Kleiner D, Haghikia A, Nonhoff J, Bauersachs J. Peripartum cardiomyopathy: current management and future perspectives. European Heart Journal. 2015;36(18):1090–7. DOI: 10.1093/eurheartj/ehv009